Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advaxis (OTCMKTS: ADXS) has recently received a number of price target changes and ratings updates: 4/11/2022 – Advaxis is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/5/2022 – Advaxis is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/4/2022 – Advaxis is […]
StockNews.com assumed coverage on shares of Advaxis (OTCMKTS:ADXS – Get Rating) in a report issued on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Shares of ADXS opened at $0.10 on Monday. Advaxis has a one year low of $0.08 and a one year high of $0.76. The company has a […]
StockNews.com assumed coverage on shares of Advaxis (NASDAQ:ADXS – Get Rating) in a research note released on Tuesday morning. The firm issued a sell rating on the stock. Shares of Advaxis stock opened at $0.10 on Tuesday. The stock has a market capitalization of $14.53 million, a PE ratio of -1.00 and a beta of […]
StockNews.com initiated coverage on shares of Advaxis (NASDAQ:ADXS – Get Rating) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the stock. ADXS opened at $0.10 on Tuesday. The company has a market cap of $15.22 million, a PE ratio of -1.05 and a beta of 2.11. Advaxis […]
Albany NY, United States: Uncontrolled proliferation of the cells in a human body leads to cervical cancer.